Dual effects of TNF on synthesis of complement components by a gastric cancer-derived cell line, KATO-III

International Archives of Allergy and Immunology

Volumn 119, Issue 1, 1999, Pages 54-59

  Kitano, Etsuko ^b   Kitamura, Hajime ^a  

^a Osaka Prefecture University   (Japan)

^b NONE

Author keywords

C2; C3; Complement synthesis; Gastric epithelial cells; KATO III; Tumor necrosis factor

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; CYCLOHEXIMIDE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNITY; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; SIGNET RING CARCINOMA; STOMACH CANCER;

COMPLEMENT ACTIVATION; COMPLEMENT C2; COMPLEMENT C3; CULTURE MEDIA; CYCLOHEXIMIDE; HUMANS; IMMUNOBLOTTING; KINETICS; MALE; MIDDLE AGED; PROTEIN SYNTHESIS INHIBITORS; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032962424     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024175     Document Type: Article

References (26)

1. Alper CA, Johnson AM, Birtch AG, Moore FD: Human C'3: Evidence for the liver as the primary site of synthesis. Science 1969;163: 286-288.
2. Morgan BP, Gasque P: Extrahepatic complement biosynthesis: Where, when and why? Clin Exp Immunol 1997;107:1-7.
3. Sundstrom SA, Komm BS, Ponce-de-Leon H, Yi Z, Teuscher C, Lyttle CR: Estrogen regulation of tissue-specific expression of complement C3. J Biol Chem 1989;264:16941-16947.
4. Strunk RC, Eidlen DM, Mason RJ: Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. J Clin Invest 1988;81: 1419-1426.
5. Brooimans RA, Stegmann APA, van Dorp WT, van der Ark AAJ, van der Woude FJ, van Es LA, Daha MR: Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J Clin Invest 1991;88:379-384.
6. Ueki A, Sai T, Oka H, Tabata T, Hosokawa K, Mochizuki Y: Biosynthesis and secretion of the third component of complement by human endothelial cells in vitro. Immunology 1987; 61:11-14.
7. Brooimans RA, Ark AAJ, Buurman WA, Es LA, Daha MR: Differential regulation of complement factor H and C3 production in human umbilical vein endothelial cells by IFN-γ and IL-1. J Immunol 1990;144:3835-3840.
8. Colten HR, Gordon JM, Rapp HJ, Borsos T: Synthesis of the first component of guinea pig complement by columnar epithelial cells of the small intestine. J Immunol 1968;100:788-792.
9. Andoh A, Fujiyama Y, Bamba T, Hosoda S: Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2. J Immunol 1993;151:4239-4247.
10. Ahrenstedt Ö, Knutson L. Nilsson B, Nilsson-Ekdahl K, Odlind B, Hallgren R: Enhanced local production of complement components in the small intestines of patients with Crohn's disease. N Engl J Med 1990;322:1345-1349.
11. Kitano E, Kitamura H: Synthesis of the third component complement (C3) by human gastric cancer-derived cell lines. Clin Exp Immunol 1993;94:273-278.
12. Andoh A, Fujiyama Y, Sakumoto H, Uchihara H, Kimura T, Koyama S, Bamba T: Detection of complement C3 and factor B gene expression in normal colorectal mucosa, adenoma and carcinomas. Clin Exp Immunol 1998;111: 477-483.
13. Naughton MA, Botto M. Carter MJ, Alexander GJM, Goldman JM, Walport MJ: Extrahepatic secreted complement C3 contributes to circulating C3 levels in human. J Immunol 1996; 156:3051-3056.
14. Molmenti EP, Ziambaras T, Perlmutter DH: Evidence for an acute phase response in human intestinal epithelial cells. J Immunol 1993;268: 14116-14124.
15. Griebel PJ, Hein WR: Expanding the role of Peyer's patches in B-cell ontogeny. Immunol Today 1996;17:30-39.
16. Wagner N, Löhler J, Kunkel EJ, Ley K, Leung E, Krissansen G, Rajewsky K, Müller W: Critical role for β7 integrins in formation of the gut-associated lymphoid tissue. Nature 1996; 382:366-370.
17. Sekiguchi M, Sakakibara K, Fujii J: Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn J Exp Med 1978; 48:61-68.
18. Naito Y, Kino I, Horiuchi K, Fujimoto D: Promotion of collagen production by human fibroblasts with gastric cancer cells in vitro. Virchows Arch 1984;46:145-154.
19. Inai S, Kitamura H, Hiramatsu S, Nagaki K: Deficiency of the ninth component of complement in man. J Clin Lab Immunol 1979;2:85-87.
20. Kitamura H, Tsuboi M: Inhibition of immune hemolysis by a serum factor found in C3-deficient subject. Immunology 1989;66:264-269.
21. Nagaki K, Iida K, Inai S: A new method for the preparation of EAC14 cell with human or guinea-pig serum. J Immunol Methods 1974;5: 307-317.
22. Towbin H, Staehelin T. Goldon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-4354.
23. Braegger CP, Nicholis S, Murch SH, Stephens S, MacDonald TT: Tumor necrosis factor-α in stool as a marker of intestinal inflammation, Lancet 1992;339:89-91.
24. van Dullemen HM, van Deventer SJH, Hommes DW. Bul HA, Jansen J, Tytgat GNJ, Woody J: Treatment of Crohn's disease with anti-tumor necrosis factor chimeric antibody (cA2). Gastroenterology 1995;109:129-135.
25. Mai UEH, Perez GIP, Wahl LM, Wahl SM, Blaser MJ, Smith PD: Soluble surface proteins from Helicobacter pyroli activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest 1991;87: 894-900.
26. Takabayashi T, Vannier E, Clark BD, Margolis NH, Dinarello CA. Burke JF, Gelfand JA: A new biologic role for C3a and C3a desArg: Regulation of TNF-α and IL-1β synthesis. J Immunol 1996;156:3455-3460.